News

MassDevice6h
BD launches next-gen AI-powered hemodynamic monitoring tech
BD (NYSE: BDX) announced today that it launched a new hemodynamic monitoring platform using predictive AI algorithms.
MassDevice7h
FDA says Q’Apel aspiration system recall is Class I following discontinuation
Q’Apel Medical announced that the FDA classified a voluntary recall of its 072 A System as Class I, the most serious kind.
MassDevice7h
BD warns on intravascular catheter
The FDA shared an alert that BD (NYSE: BDX) and its Bard subsidiary warned customers of an issue with certain intravascular ...